腎細胞癌機理研究:從RhoA透過微小核酸群調控CD44表現到生物標記及治療之研發(3/3)

Pharmacology, Toxicology and Pharmaceutical Science

1. microRNA 100%
2. Renal Cell Carcinoma 100%
3. Biological Marker 100%
4. Mouse Model 11%
5. Nude Mouse 11%
6. Histone Deacetylase 1 11%
7. Simvastatin 11%
8. Carcinogen 5%
9. Histone Deacetylase Inhibitor 5%
10. Dioxins and Dioxin-Like Compounds 5%
11. Benzyloxycarbonylleucylleucylleucinal 5%
12. Fibronectin 5%
13. Methylcholanthrene 5%
14. Dactinomycin 5%
15. Vimentin 5%
16. Calpeptin 5%
17. Survival Rate 5%
18. Nerve Cell Adhesion Molecule 5%
19. Vorinostat 5%
20. Kidney Tumour 5%
21. Luciferase 5%
22. Cycloheximide 5%
23. Neoplasm 5%
24. Combination Therapy 5%
25. Carcinogenesis 5%
26. Neutralizing Antibody 5%

Immunology and Microbiology

1. CD44 100%
2. Agonist 23%
3. Epithelial Mesenchymal Transition 15%
4. Mouse Model 15%
5. Xenograft 15%
6. Nude Mouse 15%
7. Carcinoma Cell 7%
8. Neutralizing Antibody 7%
9. Upregulation 7%
10. Survival Rate 7%
11. Cell Invasion 7%
12. Cell Proliferation 7%
13. Renal Cell Carcinoma Cell Line 7%
14. Dioxins and Dioxin-Like Compounds 7%
15. Dactinomycin 7%
16. DNA Microarray 7%
17. Neural Cell Adhesion Molecule 7%
18. Cell Migration 7%
19. Fibronectin 7%